VKORC1 antibody (N-Term)
Quick Overview for VKORC1 antibody (N-Term) (ABIN1450145)
Target
See all VKORC1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 15 amino acid synthetic peptide near the amino terminus of Human VKORC1
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- VKORC1 (Vitamin K Epoxide Reductase Complex, Subunit 1 (VKORC1))
-
Alternative Name
- VKORC1
-
Background
- Vitamin K epoxide reductase complex subunit 1 (VKORC1) is the enzyme that is responsible for reducing vitamin K 2,3-epoxide to the enzymatically activated form which is essential for blood clotting. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood-clotting proteins. Fatal bleeding can be caused by vitamin K deficiency and by the vitamin K antagonist warfarin, and it is VKORC1 that is sensitive to warfarin. In humans, mutations in this gene can be associated with deficiencies in vitamin-K-dependent clotting factors and, in humans and rats, with warfarin resistance.Synonyms: 3-epoxide reductase subunit 1, MSTP134, MSTP576, UNQ308/PRO351, VKOR, Vitamin K epoxide reductase complex subunit 1, Vitamin K1 2
-
Gene ID
- 79001
-
NCBI Accession
- NP_076869
Target
-